Aventis Pharma has reported a sales turnover of Rs 345.70 crore and a net profit of Rs 40.10 crore for the quarter ended Mar '12 Aventis Pharma has recommended a final dividend of Rs 29 per share ...

French multinational pharmaceutical and healthcare firm Sanofi has completed a £1.4 billion buy-in for its pension scheme.

Legal & General Assurance Society Limited (“Legal & General”) has completed a £1.4 billion buy-in with the Sanofi Pension Scheme (“the Scheme”), securing the benefits of 4,900 retirees and 5,600 ...

On June 23, Millennium (Cambridge, MA) and Aventis Pharma, the pharmaceutical division of Aventis (Frankfurt, Germany), announced a “groundbreaking alliance” to develop and market drugs to ...

Sanofi Pension Scheme has completed a £1.4bn (€1.7bn) buy-in securing the benefits of 4,900 retirees and 5,600 deferred ...

Learn about Aventis Pharma Ltd in Ankleshwar, Gujarat.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location. If you own or are ...

Sanofi (SAN:FP) (NASDAQ: NASDAQ:SNY) saw its price target increased by Leerink Partners from €113.00 to €120.00, while the firm maintained an Outperform rating on the company's shares. Currently ...

The bulk annuity transaction for the scheme has fully secured the benefits of 4,900 retirees and 5,600 deferred members. The ...

Learn about Aventis Pharma Ltd in Mumbai, Maharashtra.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location. If you own or are ...

Sanofi Group's listed entity in India, today announced that the Registrar of Companies had approved the company's change of name from Aventis Pharma Ltd to 'Sanofi India Ltd', with effect from May 11.